Prediction: Unilever Turnaround Could Lift Shares to $75
Unilever faces a pivotal turnaround path as portfolio reshaping and a buyback program align with a potential rally to...
Ways To Receive Cash Today Without Work
Looking for quick cash without a job? Discover various ways to receive cash today without work and boost your finances effortlessly.
25,802 articles
Bill Ackman and David Tepper Bet Big on Amazon This Week
A wave of billionaire fund managers are boosting Amazon bets as AI hype collides with a value play. Pershing Square, ...
Over Sixty Analysts Recommend Buying This Stock. Here’s Why.
More than 60 analysts now rate the stock Buy as investors await the upcoming earnings release and assess cloud, adver...
Salesforce’s Record Billion Stock-Buyback Sparks Debate
Salesforce unveils a $50 billion buyback as software stocks waver, triggering a fierce debate over whether capital sh...
Planet Labs Jumps After Hours as Backlog Surges Past $900M
Planet Labs reports a record Q4 revenue and a backlog eclipsing annual sales, spurring a sharp after hours rally as i...
Report: OpenAI Could Confidentially File for IPO Soon
Investors are watching a growing wave of AI IPO chatter. If OpenAI opts for a confidential filing, understanding the ...
Sells 38,000 Innodata Shares: A Guide for Investors
When a CEO sells 38,000 Innodata shares, investors often wonder if the move signals trouble or simply a personal liqu...
Bitcoin Plummets Lower Strategy's STRC: Market Shake
Bitcoin slid toward the $58,000 level as Strategy's STRC dropped to fresh lows and MSTR followed lower. This article ...
Broadcom Emerges as Core AI Winner, Says Wall Street Legend
A veteran investor casts Broadcom as a core AI winner, arguing durable AI demand and strategic partnerships could kee...
Here Friday’s Wall Street Analyst Calls Roil Markets
Analysts released a wave of Friday calls on major names, lifting some stocks and easing others as markets digest the ...
Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Klaviyo Director Sold Over 9,000 Shares: Investor Insight
When a Klaviyo director sold over 9,000 shares, it sparked questions about timing, risk, and company confidence. This...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status